Fine-specificity of the immune response to oxazolone. I. Contact sensitivity and early antibodies. 1981

A M Ferreira, and M Hurme, and M Kaartinen, and O Mäkelä

The specificity of the contact sensitivity induced by various chemically related oxazolones was studied. Mice were painted with 1 of them (immunogen). They were divided into several groups and challenged (ear painting on day 5) with various concentrations of either the immunogen or a related oxazolone. The degree of the contact sensitivity was estimated by ear weight or by incorporation of a DNA precursor. Higher concentrations of a challenge compound elicited a stronger DTH reaction than lower concentrations. The efficiency of each compound was defined by the concentration that caused a 30% increase of the ear weight or 150% increase of incorporation. Both represented ca. one-third of the maximal response (1/3 max), and both methods gave similar results. Two types of specificity patterns were observed. One is based on limited data, and was exhibited by the pair furyl Ox and propenyl Ox. Furyl Ox was a more efficient challenge compound than propenyl Ox when mice were primed with furyl Ox. The reverse was true when mice were primed with propenyl Ox. The other pattern was exhibited by the pair propenyl Ox and phenyl Ox. When mice had been primed with phenyl Ox, the 1/3 max response required either 3 mM phenyl Ox or 17 mM propenyl Ox (6-fold difference). The unexpected finding was that phenyl Ox was also a (2.5-fold) more efficient challenge compound for mice that had been primed with propenyl Ox (a heteroclitic contact sensitivity).

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D010081 Oxazolone Immunologic adjuvant and sensitizing agent. 2-Phenyl-4-(ethoxymethylene)oxazol-5-one,4-Ethoxymethylene-2-phenyloxazolone,4 Ethoxymethylene 2 phenyloxazolone
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D003877 Dermatitis, Contact A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms. Contact Dermatitis,Dermatitis Venenata,Eczema, Contact,Hypersensitivity, Contact,Sensitivity, Contact,Contact Dermatitides,Contact Eczema,Contact Hypersensitivities,Contact Hypersensitivity,Contact Sensitivities,Contact Sensitivity,Dermatitides, Contact,Hypersensitivities, Contact,Sensitivities, Contact
D005260 Female Females

Related Publications

A M Ferreira, and M Hurme, and M Kaartinen, and O Mäkelä
January 1969, Folia histochemica et cytochemica,
A M Ferreira, and M Hurme, and M Kaartinen, and O Mäkelä
October 1976, Journal of immunology (Baltimore, Md. : 1950),
A M Ferreira, and M Hurme, and M Kaartinen, and O Mäkelä
January 1982, International archives of allergy and applied immunology,
A M Ferreira, and M Hurme, and M Kaartinen, and O Mäkelä
January 1987, International journal of immunopharmacology,
A M Ferreira, and M Hurme, and M Kaartinen, and O Mäkelä
January 1970, International archives of allergy and applied immunology,
A M Ferreira, and M Hurme, and M Kaartinen, and O Mäkelä
January 1983, Journal of immunology (Baltimore, Md. : 1950),
A M Ferreira, and M Hurme, and M Kaartinen, and O Mäkelä
October 1985, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
A M Ferreira, and M Hurme, and M Kaartinen, and O Mäkelä
January 1989, Vox sanguinis,
A M Ferreira, and M Hurme, and M Kaartinen, and O Mäkelä
September 1978, Nature,
Copied contents to your clipboard!